Galen A. Ohnmacht

2.1k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Galen A. Ohnmacht is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Galen A. Ohnmacht has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Galen A. Ohnmacht's work include Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (4 papers). Galen A. Ohnmacht is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (4 papers). Galen A. Ohnmacht collaborates with scholars based in United States, Malaysia and Italy. Galen A. Ohnmacht's co-authors include Francesco M. Marincola, Ena Wang, Lance D. Miller, Edison T. Liu, Steven A. Rosenberg, Adam I. Riker, Monica C. Panelli, Simone Mocellin, Udai S. Kammula and Maria Bettinotti and has published in prestigious journals such as Nature Biotechnology, The Journal of Immunology and Genome biology.

In The Last Decade

Galen A. Ohnmacht

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-fidelity mRNA amplification for gene profiling

2000 557 citations Ena Wang, Lance D. Miller et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Galen A. Ohnmacht United States	16	997	809	567	152	148	18	1.7k
Kei Hiraoka Japan	20	605 0.6×	887 1.1×	1.2k 2.2×	214 1.4×	281 1.9×	41	2.1k
D. Ockert Germany	15	358 0.4×	345 0.4×	582 1.0×	125 0.8×	94 0.6×	47	1.2k
J Tschopp Switzerland	9	866 0.9×	937 1.2×	438 0.8×	216 1.4×	102 0.7×	10	1.6k
N Odartchenko Switzerland	23	721 0.7×	341 0.4×	383 0.7×	164 1.1×	226 1.5×	53	1.7k
Mark A. Wechser United States	8	755 0.8×	600 0.7×	341 0.6×	219 1.4×	59 0.4×	9	1.6k
C. Henne Germany	10	737 0.7×	551 0.7×	310 0.5×	124 0.8×	66 0.4×	15	1.2k
Erica N Evans United States	19	487 0.5×	379 0.5×	187 0.3×	75 0.5×	80 0.5×	44	1.2k
Allison R. Greenplate United States	19	526 0.5×	681 0.8×	465 0.8×	178 1.2×	91 0.6×	31	1.3k
F Birg France	24	860 0.9×	528 0.7×	383 0.7×	103 0.7×	248 1.7×	44	1.9k
Andrew J. Bredemeyer United States	13	496 0.5×	475 0.6×	285 0.5×	320 2.1×	186 1.3×	16	1.3k

Countries citing papers authored by Galen A. Ohnmacht

Since Specialization

Citations

This map shows the geographic impact of Galen A. Ohnmacht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen A. Ohnmacht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen A. Ohnmacht more than expected).

Fields of papers citing papers by Galen A. Ohnmacht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galen A. Ohnmacht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen A. Ohnmacht. The network helps show where Galen A. Ohnmacht may publish in the future.

Co-authorship network of co-authors of Galen A. Ohnmacht

This figure shows the co-authorship network connecting the top 25 collaborators of Galen A. Ohnmacht. A scholar is included among the top collaborators of Galen A. Ohnmacht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galen A. Ohnmacht. Galen A. Ohnmacht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Ohnmacht, Galen A., Mark S. Allen, Stephen D. Cassivi, et al.. (2006). Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Diseases of the Esophagus. 19(4). 311–312. 29 indexed citations

2.

Ohnmacht, Galen A., Claude Deschamps, Stephen D. Cassivi, et al.. (2006). Failed Antireflux Surgery: Results After Reoperation. The Annals of Thoracic Surgery. 81(6). 2050–2054. 47 indexed citations

3.

Panelli, Monica C., Ena Wang, Giao Q. Phan, et al.. (2002). Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome biology. 3(7). RESEARCH0035–RESEARCH0035. 149 indexed citations

4.

Wang, Ena, Lance D. Miller, Galen A. Ohnmacht, et al.. (2002). Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.. PubMed. 62(13). 3581–6. 198 indexed citations

5.

Ohnmacht, Galen A., Ena Wang, Simone Mocellin, et al.. (2001). Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination. The Journal of Immunology. 167(3). 1809–1820. 69 indexed citations

6.

Weiser, Todd S., Zong Sheng Guo, Galen A. Ohnmacht, et al.. (2001). Sequential 5-Aza-2’-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1. Journal of Immunotherapy. 24(2). 151–161. 142 indexed citations

7.

Weiser, Todd S., Galen A. Ohnmacht, Zong Sheng Guo, et al.. (2001). Induction of MAGE-3 expression in lung and esophageal cancer cells. The Annals of Thoracic Surgery. 71(1). 295–302. 70 indexed citations

8.

Mocellin, Simone, Galen A. Ohnmacht, Maria Bettinotti, et al.. (2001). Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading. International Journal of Cancer. 93(6). 841–847. 45 indexed citations

9.

Mocellin, Simone, et al.. (2001). Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness. International Journal of Cancer. 93(2). 236–242. 47 indexed citations

10.

Harada, Mamoru, Yong F. Li, Mona El‐Gamil, et al.. (2001). Melanoma-Reactive CD8 + T Cells Recognize a Novel Tumor Antigen Expressed in a Wide Variety of Tumor Types. Journal of Immunotherapy. 24(4). 323–333. 27 indexed citations

11.

Ohnmacht, Galen A., Giao Q. Phan, Sharon Mavroukakis, et al.. (2001). A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2. Journal of Immunotherapy. 24(2). 188–192. 1 indexed citations

12.

Hanada, Ken‐ichi, Donna Perry-Lalley, Galen A. Ohnmacht, Maria Bettinotti, & James C. Yang. (2001). Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.. PubMed. 61(14). 5511–6. 53 indexed citations

13.

Panelli, Monica C., Maria Bettinotti, Galen A. Ohnmacht, et al.. (2000). A Tumor-Infiltrating Lymphocyte from a Melanoma Metastasis with Decreased Expression of Melanoma Differentiation Antigens Recognizes MAGE-12. The Journal of Immunology. 164(8). 4382–4392. 44 indexed citations

14.

Wang, Ena, Lance D. Miller, Galen A. Ohnmacht, Edison T. Liu, & Francesco M. Marincola. (2000). High-fidelity mRNA amplification for gene profiling. Nature Biotechnology. 18(4). 457–459. 557 indexed citations breakdown →

15.

Riker, Adam I., Udai S. Kammula, Monica C. Panelli, et al.. (2000). Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes. International Journal of Cancer. 86(6). 818–826. 54 indexed citations

16.

Ohnmacht, Galen A. & Francesco M. Marincola. (2000). Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma. Journal of Cellular Physiology. 182(3). 332–338. 27 indexed citations

17.

Riker, Adam I., Udai S. Kammula, Monica C. Panelli, et al.. (2000). Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes. International Journal of Cancer. 86(6). 818–826. 1 indexed citations

18.

Kammula, Udai S., Adam I. Riker, Ena Wang, et al.. (1999). Functional Analysis of Antigen-Specific T Lymphocytes by Serial Measurement of Gene Expression in Peripheral Blood Mononuclear Cells and Tumor Specimens. The Journal of Immunology. 163(12). 6867–6875. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact